← All trials
NCT01619462
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2011
- Primary completion
- Apr 1, 2014
- Completion date
- Nov 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Papua New Guinea Institute of Medical ResearchLead sponsor
- Papua New Guinea Institute of Medical ResearchOverall official - principal investigator
- Telethon Institute for Child Health ResearchOverall official - principal investigator
- University of Western AustraliaOverall official - principal investigator
- University of Western AustraliaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.